Gut microbiota and GLP-1. (Q38208787)

31 August 2017

Gut microbiota and GLP-1. (English)

1 reference

31 August 2017

2

1 reference

31 August 2017

Amandine Everard

1

1 reference

PubMed ID

24789701

31 August 2017

language of work or name

1 reference

1 September 2014

1 reference

Reviews in Endocrine and Metabolic Disorders

31 August 2017

1 reference

31 August 2017

15

1 reference

31 August 2017

189-196

1 reference

31 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-014-9288-6

31 August 2017

0 references

cites work

Bacterial community variation in human body habitats across space and time

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Intestinal microbiota during infancy and its implications for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Microbial ecology of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Gut microbiota composition correlates with diet and health in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The human gut microbiome and its dysfunctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Function of the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Diabetes, obesity and gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The role of the gut microbiota in energy metabolism and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Functional interactions between the gut microbiota and host metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The gut microbiota shapes intestinal immune responses during health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Bacteria as vitamin suppliers to their host: a gut microbiota perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The role of the gut microbiota in nutrition and health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Gut microbiota, enteroendocrine functions and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Gut microbiota and metabolic disorders: How prebiotic can work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Resistant starch: promise for improving human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

A review of the role of soluble fiber in health with specific reference to wheat dextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The impact of nutrition on the human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and relationship to plasma gastrin, enteroglucagon, and PYY concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Proglucagon-derived peptides: mechanisms of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Short-chain fatty acid release of peptide YY in the isolated rabbit distal colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Prebiotic effects: metabolic and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Impact of inulin and oligofructose on gastrointestinal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Dietary resistant starch increases hypothalamic POMC expression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Peptide YY and proglucagon mRNA expression patterns and regulation in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Consumption of diets high in prebiotic fiber or protein during growth influences the response to a high fat and sucrose diet in adulthood in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Differential secretion of satiety hormones with progression of obesity in JCR:LA-corpulent rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Effect of fat replacement by inulin or lupin-kernel fibre on sausage patty acceptability, post-meal perceptions of satiety and food intake in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Oligofructose promotes satiety in healthy human: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Effect of large bowel fermentation on insulin, glucose, free fatty acids, and glucagon-like peptide 1 (7-36) amide in patients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Dietary-resistant starch and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

RD Lawrence Lecture 2008: Targeting GLP-1 release as a potential strategy for the therapy of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Microbial modulation of energy availability in the colon regulates intestinal transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Functional analysis of colonic bacterial metabolism: relevant to health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

An anorexic lipid mediator regulated by feeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The expanding field of cannabimimetic and related lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Regulation of GPR119 receptor activity with endocannabinoid-like lipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

The endocannabinoid system links gut microbiota to adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Gustducin couples fatty acid receptors to GLP-1 release in colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11154-014-9288-6

Colonic fermentation and proximal gastric tone in humans

21 January 2018

1 reference

12 December 2020

Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics

1 reference

12 December 2020

Fermentable carbohydrates elevate plasma enteroglucagon but high viscosity is also necessary to stimulate small bowel mucosal cell proliferation in rats

1 reference

12 December 2020

High fat diet partially attenuates fermentation responses in rats fed resistant starch from high-amylose maize

1 reference

12 December 2020

Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats

1 reference

12 December 2020

Appetite during consumption of enteral formula as a sole source of nutrition: the effect of supplementing pea-fibre and fructo-oligosaccharides

1 reference

12 December 2020

Contribution of the intestinal microbiota to human health: from birth to 100 years of age.

1 reference

12 December 2020

Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake

1 reference

12 December 2020

Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet

1 reference

12 December 2020

Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats.

1 reference

12 December 2020

Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats

1 reference

12 December 2020

Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal

1 reference

12 December 2020

Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats

1 reference

12 December 2020

Energy contributions of volatile fatty acids from the gastrointestinal tract in various species

1 reference

12 December 2020

Resistant starch and pullulan reduce postprandial glucose, insulin, and GLP-1, but have no effect on satiety in healthy humans

1 reference

12 December 2020

No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake

1 reference

12 December 2020

Fiber and prebiotics: mechanisms and health benefits

1 reference

12 December 2020

Messages from the Inside. The Dynamic Environment that Favors Intestinal Homeostasis

1 reference

12 December 2020

Probiotics, prebiotics, and the host microbiome: the science of translation

1 reference

12 December 2020

Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study

1 reference

12 December 2020

10.1007/S11154-014-9288-6

Identifiers

DOI

1 reference

PubMed ID

24789701

Dimensions Publication ID

31 August 2017

0 references

1 reference

PubMed ID

24789701